Patents by Inventor Sadahiro MIYAMURA

Sadahiro MIYAMURA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition including sodium alkyl sulfate
    Patent number: 11833151
    Abstract: The object of the present invention is to improve the dissolution and the absorption of (S)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl-1-pyrrolidinyl)-2-propen-1-one effective as an antitumor agent from a pharmaceutical formulation comprising the same. Provided is a pharmaceutical composition comprising (S)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl-1-pyrrolidinyl)-2-propen-1-one in combination with sodium alkyl sulfate having an alkyl group containing 10 to 18 carbon atoms, in particular, with sodium lauryl sulfate.
    Type: Grant
    Filed: March 18, 2019
    Date of Patent: December 5, 2023
    Assignee: Taiho Pharmaceutical Co., Ltd.
    Inventors: Kenji Kusumoto, Sadahiro Miyamura
  • PHARMACEUTICAL COMPOSITION INCLUDING SODIUM ALKYL SULFATE
    Publication number: 20210030755
    Abstract: The object of the present invention is to improve the dissolution and the absorption of (S)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl-1-pyrrolidinyl)-2-propen-1-one effective as an antitumor agent from a pharmaceutical formulation comprising the same. Provided is a pharmaceutical composition comprising (S)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl-1-pyrrolidinyl)-2-propen-1-one in combination with sodium alkyl sulfate having an alkyl group containing 10 to 18 carbon atoms, in particular, with sodium lauryl sulfate.
    Type: Application
    Filed: March 18, 2019
    Publication date: February 4, 2021
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Kenji KUSUMOTO, Sadahiro MIYAMURA